Latest Articles
Decoding high-grade endometrial cancer: a molecular-histologic integration using the Cancer Genome Atlas framework - EurekAlert!
Decoding high-grade endometrial cancer: a molecular-histologic integration using the Cancer Genome Atlas framework EurekAlert!
Published: Sept. 10, 2025, 2:24 p.m.
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation - Rare Cancer News
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation Rare Cancer News
Published: Sept. 10, 2025, 12:49 p.m.
My doctor insisted my cancer hadn’t returned — this sign made me seek a second opinion, I found out it was stage 4 - New York Post
My doctor insisted my cancer hadn’t returned — this sign made me seek a second opinion, I found out it was stage 4 New York Post
Published: Sept. 10, 2025, 10 a.m.
Prevention Is Power: Learning the Secrets to Reducing the Risks of Gynecologic Cancers - Johns Hopkins University
Prevention Is Power: Learning the Secrets to Reducing the Risks of Gynecologic Cancers Johns Hopkins University
Published: Sept. 9, 2025, 5:46 p.m.
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them - NewsBreak: Local News & Alerts
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them NewsBreak: Local News & Alerts
Published: Sept. 9, 2025, 3:28 p.m.
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them - Everyday Health
9 Endometrial Cancer Treatment Side Effects, and How to Manage Them Everyday Health
Published: Sept. 9, 2025, 3:15 p.m.
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study - TipRanks
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study TipRanks
Published: Sept. 7, 2025, 5:31 p.m.
Endometrial cancer: new markers for PET imaging - healthcare-in-europe.com
Endometrial cancer: new markers for PET imaging healthcare-in-europe.com
Published: Sept. 7, 2025, 6:23 a.m.
Risk of Abortion and Ectopic Pregnancy in Women with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study.
Objectives: The purpose of this retrospective cohort study was to ascertain the risk of abortion, ectopic pregnancy and hydatidiform mole development in women with polycystic ovary syndrome (PCOS) using data …
Published: Sept. 7, 2025, midnight
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance
Published: Sept. 6, 2025, 11:31 a.m.
Link copied to clipboard!